Tenaya Therapeutics, Inc.
TNYA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $56 | $63 | $54 | $4 |
| Short-Term Investments | $0 | $9 | $34 | $57 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5 | $4 | $6 | $6 |
| Total Curr. Assets | $61 | $76 | $94 | $67 |
| Property Plant & Equip (Net) | $39 | $42 | $45 | $48 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $4 | $4 | $5 | $5 |
| Total NC Assets | $44 | $46 | $49 | $53 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $105 | $122 | $144 | $120 |
| Liabilities | – | – | – | – |
| Payables | $3 | $3 | $5 | $5 |
| Short-Term Debt | $3 | $3 | $3 | $3 |
| Tax Payable | $0 | $1 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $7 | $6 | $6 | $8 |
| Total Curr. Liab. | $13 | $13 | $14 | $16 |
| LT Debt | $9 | $9 | $10 | $11 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $9 | $10 | $10 | $11 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $12 | $13 | $14 |
| Total Liabilities | $22 | $22 | $25 | $27 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$585 | -$565 | -$541 | -$514 |
| AOCI | $0 | -$0 | -$0 | $0 |
| Other Equity | $668 | $664 | $661 | $607 |
| Total Equity | $83 | $100 | $119 | $93 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $105 | $122 | $144 | $120 |
| Net Debt | -$45 | -$50 | -$41 | $9 |